Cargando…

Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden

IMPORTANCE: Neurocutaneous syndromes are associated with cancer predisposition and sometimes associated with perinatal factors. A better understanding of the association between neurocutaneous syndromes, perinatal factors, and childhood cancer is key for earlier cancer detection. OBJECTIVE: To evalu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kampitsi, Christina-Evmorfia, Nordgren, Ann, Mogensen, Hanna, Pontén, Emeli, Feychting, Maria, Tettamanti, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370257/
https://www.ncbi.nlm.nih.gov/pubmed/37490289
http://dx.doi.org/10.1001/jamanetworkopen.2023.25482
_version_ 1785077911432200192
author Kampitsi, Christina-Evmorfia
Nordgren, Ann
Mogensen, Hanna
Pontén, Emeli
Feychting, Maria
Tettamanti, Giorgio
author_facet Kampitsi, Christina-Evmorfia
Nordgren, Ann
Mogensen, Hanna
Pontén, Emeli
Feychting, Maria
Tettamanti, Giorgio
author_sort Kampitsi, Christina-Evmorfia
collection PubMed
description IMPORTANCE: Neurocutaneous syndromes are associated with cancer predisposition and sometimes associated with perinatal factors. A better understanding of the association between neurocutaneous syndromes, perinatal factors, and childhood cancer is key for earlier cancer detection. OBJECTIVE: To evaluate the association of neurocutaneous syndromes and perinatal factors with childhood cancer risk in a cohort of Swedish children. DESIGN, SETTING, AND PARTICIPANTS: In this nationwide cohort study, all children and adolescents up to age 20 years, from 1973 to 2015, were identified through the Swedish National Medical Birth Register (MBR), provided they had information on both biological parents. Analyses were conducted from April 2021 through May 2023. EXPOSURES: Diagnoses of neurocutaneous syndromes were obtained from the MBR, National Patient Register, and Cause of Death register. Perinatal factors (birth weight, gestational age, birth weight by gestational age, 5-minute Apgar score, and head circumference) were obtained from the MBR. MAIN OUTCOMES AND MEASURES: Childhood cancer risk (<20 years at diagnosis; identified from the National Cancer Register), including leukemia, lymphoma, and central nervous system (CNS) tumors. RESULTS: Among 4 173 108 included children (2 143 133 [51.4%] male, median [IQR] follow-up 20 [9.7-20] years), 1783 had neurofibromatosis type 1 (NF1), 444 tuberous sclerosis, 63 von Hippel-Lindau disease, and 39 ataxia-telangiectasia. An increased cancer risk was observed among children with any neurocutaneous syndrome (HR, 34.9; 95% CI, 30.8-39.6) and was particularly pronounced for CNS tumors (HR, 111.7; 95% CI, 96.8-128.8), except among children with ataxia-telangiectasia, where the increased risk was associated with lymphomas (HR, 233.1; 95% CI, 75.0-724.1). Leukemia risk was increased only among children with NF1 (HR, 4.1; 95% CI, 1.7-9.8). Several perinatal factors, including high birth weight, being born large for gestational age, preterm birth, low 5-minute Apgar score, and large head circumference had lesser associations with childhood cancer. Adjusting for neurocutaneous syndromes did not affect these associations. CONCLUSIONS AND RELEVANCE: In this nationwide cohort study, neurocutaneous syndromes were associated with an increased risk of childhood cancer, especially CNS tumors. Several perinatal factors had lesser associations with childhood cancer, independently of the presence of neurocutaneous syndromes. Other biological mechanisms likely underlie the association between perinatal factors and childhood cancer.
format Online
Article
Text
id pubmed-10370257
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-103702572023-07-27 Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden Kampitsi, Christina-Evmorfia Nordgren, Ann Mogensen, Hanna Pontén, Emeli Feychting, Maria Tettamanti, Giorgio JAMA Netw Open Original Investigation IMPORTANCE: Neurocutaneous syndromes are associated with cancer predisposition and sometimes associated with perinatal factors. A better understanding of the association between neurocutaneous syndromes, perinatal factors, and childhood cancer is key for earlier cancer detection. OBJECTIVE: To evaluate the association of neurocutaneous syndromes and perinatal factors with childhood cancer risk in a cohort of Swedish children. DESIGN, SETTING, AND PARTICIPANTS: In this nationwide cohort study, all children and adolescents up to age 20 years, from 1973 to 2015, were identified through the Swedish National Medical Birth Register (MBR), provided they had information on both biological parents. Analyses were conducted from April 2021 through May 2023. EXPOSURES: Diagnoses of neurocutaneous syndromes were obtained from the MBR, National Patient Register, and Cause of Death register. Perinatal factors (birth weight, gestational age, birth weight by gestational age, 5-minute Apgar score, and head circumference) were obtained from the MBR. MAIN OUTCOMES AND MEASURES: Childhood cancer risk (<20 years at diagnosis; identified from the National Cancer Register), including leukemia, lymphoma, and central nervous system (CNS) tumors. RESULTS: Among 4 173 108 included children (2 143 133 [51.4%] male, median [IQR] follow-up 20 [9.7-20] years), 1783 had neurofibromatosis type 1 (NF1), 444 tuberous sclerosis, 63 von Hippel-Lindau disease, and 39 ataxia-telangiectasia. An increased cancer risk was observed among children with any neurocutaneous syndrome (HR, 34.9; 95% CI, 30.8-39.6) and was particularly pronounced for CNS tumors (HR, 111.7; 95% CI, 96.8-128.8), except among children with ataxia-telangiectasia, where the increased risk was associated with lymphomas (HR, 233.1; 95% CI, 75.0-724.1). Leukemia risk was increased only among children with NF1 (HR, 4.1; 95% CI, 1.7-9.8). Several perinatal factors, including high birth weight, being born large for gestational age, preterm birth, low 5-minute Apgar score, and large head circumference had lesser associations with childhood cancer. Adjusting for neurocutaneous syndromes did not affect these associations. CONCLUSIONS AND RELEVANCE: In this nationwide cohort study, neurocutaneous syndromes were associated with an increased risk of childhood cancer, especially CNS tumors. Several perinatal factors had lesser associations with childhood cancer, independently of the presence of neurocutaneous syndromes. Other biological mechanisms likely underlie the association between perinatal factors and childhood cancer. American Medical Association 2023-07-25 /pmc/articles/PMC10370257/ /pubmed/37490289 http://dx.doi.org/10.1001/jamanetworkopen.2023.25482 Text en Copyright 2023 Kampitsi CE et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
Kampitsi, Christina-Evmorfia
Nordgren, Ann
Mogensen, Hanna
Pontén, Emeli
Feychting, Maria
Tettamanti, Giorgio
Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title_full Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title_fullStr Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title_full_unstemmed Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title_short Neurocutaneous Syndromes, Perinatal Factors, and the Risk of Childhood Cancer in Sweden
title_sort neurocutaneous syndromes, perinatal factors, and the risk of childhood cancer in sweden
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10370257/
https://www.ncbi.nlm.nih.gov/pubmed/37490289
http://dx.doi.org/10.1001/jamanetworkopen.2023.25482
work_keys_str_mv AT kampitsichristinaevmorfia neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden
AT nordgrenann neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden
AT mogensenhanna neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden
AT pontenemeli neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden
AT feychtingmaria neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden
AT tettamantigiorgio neurocutaneoussyndromesperinatalfactorsandtheriskofchildhoodcancerinsweden